Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial

Early experience in MS generated concerns that interferon beta treatment might provoke onset or worsening of depression. The objective of the study was to compare depression incidence in relapsing–remitting MS patients receiving interferon beta-1b (IFNB-1b) or glatiramer acetate (GA) in the BEYOND t...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Neurol
मुख्य लेखकों: Schippling, Sven, O’Connor, Paul, Knappertz, Volker, Pohl, Christoph, Bogumil, Timon, Suarez, Gustavo, Cook, Stuart, Filippi, Massimo, Hartung, Hans-Peter, Comi, Giancarlo, Jeffery, Douglas R., Kappos, Ludwig, Goodin, Douglas S., Arnason, Barry
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Springer Berlin Heidelberg 2016
विषय:
Original Communication
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4929160/
https://ncbi.nlm.nih.gov/pubmed/27177997
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00415-016-8146-8
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन